Calidi Biotherapeutics, Inc. (CLDI)
1.12
+0.02
(+1.82%)
USD |
NYAM |
Sep 21, 16:00
1.18
+0.06
(+5.36%)
After-Hours: 20:00
Calidi Biotherapeutics Market Cap : 2.333M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 2.291M |
| September 17, 2026 | 2.645M |
| September 16, 2026 | 2.437M |
| September 15, 2026 | 2.437M |
| September 14, 2026 | 2.541M |
| September 11, 2026 | 2.582M |
| September 10, 2026 | 2.728M |
| September 09, 2026 | 2.832M |
| September 08, 2026 | 2.812M |
| September 04, 2026 | 2.884M |
| September 03, 2026 | 2.812M |
| September 02, 2026 | 2.791M |
| September 01, 2026 | 2.770M |
| August 31, 2026 | 2.791M |
| August 28, 2026 | 2.749M |
| August 27, 2026 | 2.707M |
| August 26, 2026 | 2.812M |
| August 25, 2026 | 2.728M |
| August 24, 2026 | 2.874M |
| August 21, 2026 | 2.791M |
| August 20, 2026 | 2.791M |
| August 19, 2026 | 2.874M |
| August 18, 2026 | 2.645M |
| August 17, 2026 | 2.832M |
| August 14, 2026 | 3.311M |
| Date | Value |
|---|---|
| August 13, 2026 | 3.207M |
| August 12, 2026 | 3.395M |
| August 11, 2026 | 3.416M |
| August 10, 2026 | 1.201M |
| August 07, 2026 | 1.194M |
| August 06, 2026 | 1.319M |
| August 05, 2026 | 1.297M |
| August 04, 2026 | 1.392M |
| August 03, 2026 | 1.238M |
| July 31, 2026 | 1.208M |
| July 30, 2026 | 1.100M |
| July 29, 2026 | 1.100M |
| July 28, 2026 | 1.266M |
| July 27, 2026 | 20.65M |
| July 24, 2026 | 18.86M |
| July 23, 2026 | 19.80M |
| July 22, 2026 | 19.91M |
| July 21, 2026 | 18.76M |
| July 20, 2026 | 21.80M |
| July 17, 2026 | 22.42M |
| July 16, 2026 | 21.80M |
| July 15, 2026 | 23.18M |
| July 14, 2026 | 23.01M |
| July 13, 2026 | 25.03M |
| July 10, 2026 | 26.57M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.710B |
| Oncolytics Biotech, Inc. | 95.71M |
| Sangamo Therapeutics, Inc. | 60.03M |
| Sarepta Therapeutics, Inc. | 2.126B |
| Anixa Biosciences, Inc. | 93.38M |
Market Cap Related Metrics
| Price to Book Value | 0.7445 |
| Price | 1.12 |
| Earnings Yield | -4.83K% |